Jaye L. Thompson
Chief Tech/Sci/R&D Officer at GREENWICH LIFESCIENCES, INC.
Net worth: 5 M $ as of 2024-03-30
Network origin in Jaye L. Thompson first degree
Entity | Entity type | Industry | |
---|---|---|---|
Holding Company | Pharmaceuticals: Major | 11 | |
Unknown | 6 | ||
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.
5
| Extinct | Pharmaceuticals: Major | 5 |
inVentiv Clinical Solutions LLC
1
| Subsidiary | 1 | |
Gulf Coast Regional Center of Innovation & Commercialization
1
| Non-Profit Organization | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jaye L. Thompson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Graduate Degree | |
Eagle Asset Management, Inc.
Eagle Asset Management, Inc. Investment ManagersFinance Eagle Asset Management, Inc. (Eagle) is a SEC-registered investment advisor headquartered in St. Petersburg, Florida. The firm was founded in 1976 by Tom James and is a wholly owned subsidiary of Carillon Towers Advisers, Inc., which is wholly owned by Raymond James Financial, Inc. (NYSE: RJF). Eagle provides portfolio management services to institutions and high net-worth clients (individual investors, trusts and smaller employee benefit plans) and serves as the investment subadvisor to the Carillon Funds. | Investment Managers | Analyst-Equity | |
Voya Investment Management Co. LLC
Voya Investment Management Co. LLC Investment ManagersFinance Voya Investment Management Co. LLC (Voya IM) is a SEC-registered investment advisor and mutual fund manager headquartered in New York City. Formerly known as ING Investment Management Co. LLC, the firm was founded in 1972 under the name of Aetna Capital Management, Inc. They are a wholly-owned subsidiary of Voya Investment Management LLC, ultimately held by Voya Financial, Inc. (NYSE: VOYA). Voya IM provides investment management services to a wide range of clients and investment vehicles. | Investment Managers | Analyst-Equity | |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chief Operating Officer | |
PLETHORA SOLUTIONS HOLDINGS PLC | Pharmaceuticals: Major | Founder | |
TAIHUA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Axellis, Inc.
Axellis, Inc. Medical DistributorsDistribution Services Axellis, Inc. sells and distributes medical devices. Its products are used for oncology and cardiology. The company was founded in August 2007 and is headquartered in London, UK | Medical Distributors | Director/Board Member | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree | |
REGENT PACIFIC GROUP LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Aberdeen | College/University | Undergraduate Degree | |
University of Medicine & Dentistry of New Jersey | College/University | Doctorate Degree | |
Clark University | College/University | Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
University of Bristol | College/University | Doctorate Degree Undergraduate Degree | |
University of Michigan | College/University | Masters Business Admin | |
University of Nebraska Medical Center | College/University | Doctorate Degree | |
Indian Institute of Technology New Delhi | College/University | Undergraduate Degree | |
The State University of New York | College/University | Graduate Degree | |
Universidad Complutense de Madrid | College/University | Masters Business Admin | |
Technology & Entrepreneurship Center of Houston
Technology & Entrepreneurship Center of Houston Investment ManagersFinance Technology & Entrepreneurship Center of Houston operates as a non-profit organization created to accelerate the growth of Houston’s innovation ecosystem. It aligns ecosystem support around strategic initiatives that are connecting, attracting, and promoting startups, investors, corporations, government, and universities. The company was founded in October 2017 and is headquartered in Houston, TX. | Investment Managers | Director/Board Member Chief Executive Officer | |
U.S. Anti-Doping Agency
U.S. Anti-Doping Agency Medical/Nursing ServicesHealth Services U.S. Anti-Doping Agency is a non-profit organisation. It is the national anti-doping organization in the United States for Olympic, Paralympic, Pan American, and Parapan American sport. The company is charged with managing the anti-doping program, including in-competition and out-of competition testing, results management processes, drug reference resources, and athlete education for all United States Olympic Committee recognized sport national governing bodies, their athletes, and events. It contributes to the advancement of clean sport through scientific research and education & outreach initiatives focused on awareness and prevention. The company was founded on October 1, 2000 and is headquartered in Colorado Springs, CO. | Medical/Nursing Services | Director/Board Member | |
Morvus Technology Ltd.
Morvus Technology Ltd. Pharmaceuticals: GenericHealth Technology Morvus Technology Ltd. discovers, develops and commercializes of novel drugs and technologies in the oncology field. Its products include clinical candidates, research portfolio and non-core programmes. The company was founded by Philip John Burke and Roger Geoffrey Melton in April 2004 and is headquartered in Carmarthen, the United Kingdom. | Pharmaceuticals: Generic | Chairman | |
Enzo Therapeutics, Inc. | President | ||
Conagra (UK) Ltd.
Conagra (UK) Ltd. Chemicals: AgriculturalProcess Industries Conagra (UK) Ltd. engages in the selling and distribution of agrichemicals, pesticides, and processing of the frozen meat products. The company is located in London, UK. | Chemicals: Agricultural | Corporate Officer/Principal | |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer | |
Sage Healthcare Ltd.
Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Sage Healthcare Ltd. provides management consulting services to the healthcare industry. The firm's services include strategic analysis and development; mergers and acquisitions; business development, support, and planning; corporate partnering; licensing and venturing; technology and compound brokerage; valuations and value-enhancement planning; forecasting; risk assessment and due diligence; and commercial and technical assessment. The company was founded in 1995 and is headquartered in Great Shelford, GB. | Miscellaneous Commercial Services | Director/Board Member | |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services The British Society for Immunology provides membership organization services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
3-D Computer Systems, Inc.
3-D Computer Systems, Inc. Information Technology ServicesTechnology Services 3-D Computer Systems, Inc. provides computer repair services. The company was founded in 1982 and is headquartered in Cincinnati, OH. | Information Technology Services | President | |
GlycoMar Ltd.
GlycoMar Ltd. Medical SpecialtiesHealth Technology Part of Aytu Biopharma, Inc., GlycoMar Ltd. is a European center for marine biotechnology and glycobiology. The private company is based in Oban, UK. The British company pursues untapped biological and chemical diversity to identify new drug candidates from marine organisms. GlycoMar was acquired by Rosewind Corp. on January 11, 2013 for $13.01 million. | Medical Specialties | Chairman | |
Global Pharma Consulting Ltd. | Founder | ||
Plethora Solutions Ltd.
Plethora Solutions Ltd. Hospital/Nursing ManagementHealth Services Part of Regent Pacific Group Ltd., Plethora Solutions Ltd. is a specialty pharmaceutical company based in Chalgrove, UK. The British company's principal product is a treatment remedy for male premature ejaculation, which obtained marketing authorization from the European Commission in 2013. With more than 25 million men suffering from premature ejaculation, the private company aims to meet the poorly met medical needs of this expanding market. The company provides information on their website for business development and investor relations purposes only, and patients who suffer from premature ejaculation should contact their physician in the first instance. Founded in 2003, the company is dedicated to developing and marketing products for the treatment and management of urological disorders. | Hospital/Nursing Management | Director/Board Member | |
Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
Mens Health Ltd. | Director/Board Member | ||
Antag Therapeutics ApS
Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Titania Partners LLC
Titania Partners LLC Financial ConglomeratesFinance Titania Partners LLC provides financial services. The private company is based in The Woodlands, TX. | Financial Conglomerates | Director/Board Member | |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | Chief Executive Officer | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Phenolics, LLC | Corporate Officer/Principal | ||
PharmaPrint LLC | Corporate Officer/Principal | ||
ADICET BIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
United States | 32 |
United Kingdom | 14 |
Hong Kong | 2 |
India | 2 |
Spain | 2 |
Sectoral
Health Technology | 17 |
Consumer Services | 16 |
Finance | 5 |
Commercial Services | 4 |
Health Services | 3 |
Operational
Director/Board Member | 83 |
Corporate Officer/Principal | 37 |
Chief Executive Officer | 34 |
President | 30 |
Independent Dir/Board Member | 27 |
Most connected contacts
Insiders | |
---|---|
David Hung | 24 |
Sona Saira Ramasastry | 19 |
Gail Maderis | 19 |
David McWilliams | 19 |
Larry Dillaha | 13 |
Michael Wyllie | 12 |
Patrick P. Fourteau | 11 |
F. Daugherty | 11 |
Mark Lappe | 8 |
Karthik Radhakrishnan | 8 |
Donald Healey | 7 |
Eric Rothe | 7 |
Jean L. Fourcroy | 6 |
Walter Ulrich | 6 |
Christine T. Fischette | 6 |
- Stock Market
- Insiders
- Jaye L. Thompson
- Company connections